🇺🇸 FDA
Pipeline program

CHO-H01

NHLHAT-001

Phase 2 small_molecule active

Quick answer

CHO-H01 for Non-Hodgkin Lymphoma is a Phase 2 program (small_molecule) at Cho Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Cho Pharma
Indication
Non-Hodgkin Lymphoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials